Faes Farma, S.A. (BME:FAE)

Market Cap	1.44B +2.7%
Revenue (ttm)	674.06M +28.6%
Net Income	82.04M -24.9%
EPS	0.26
Shares Out	311.26M
PE Ratio	17.55
Forward PE	4.57
Dividend	0.18 (3.87%)
Ex-Dividend Date	Jul 2, 2026

Volume	n/a
Open	4.620
Previous Close	4.620
Day's Range	4.575 - 4.630
52-Week Range	4.100 - 5.440
Beta	0.34
Analysts	Hold
Price Target	5.39 (+16.67%)
Earnings Date	Jul 27, 2026

About Faes Farma

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants services, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securiti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1933
• Employees: 2,681
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: FAE

Financial Performance

In 2025, Faes Farma's revenue was 626.99 million, an increase of 22.93% compared to the previous year's 510.04 million. Earnings were 79.63 million, a decrease of -28.49%.

Analyst Summary

According to 4 analysts, the average rating for FAE stock is "Hold." The 12-month stock price target is €5.39, which is an increase of 16.67% from the latest price.

Price Target

€5.39

(16.67% upside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 26, 2026

Data Sources Report a data error